Covea Finance Repligen Corp Transaction History

Covea Finance

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$138.78 - $176.51 $180,414 - $229,463	1,300 Added 18.57%	8,300 $1.32 Million
Q1 2023 Apr 17, 2023	SELL	$154.26 - $198.1 $308,520 - $396,200	-2,000 Reduced 22.22%	7,000 $1.18 Million
Q3 2022 Oct 27, 2022	BUY	$160.42 - $256.21 $1.44 Million - $2.31 Million	9,000 New	9,000 $1.68 Million

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Covea Finance, based on Form 13F filings with the SEC.

Stay updated on Covea Finance with notifications on news.